Helen M. Burt

9.8k total citations · 1 hit paper
168 papers, 8.0k citations indexed

About

Helen M. Burt is a scholar working on Oncology, Biomaterials and Molecular Biology. According to data from OpenAlex, Helen M. Burt has authored 168 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 45 papers in Biomaterials and 34 papers in Molecular Biology. Recurrent topics in Helen M. Burt's work include Nanoparticle-Based Drug Delivery (34 papers), Cancer Treatment and Pharmacology (23 papers) and Advanced Drug Delivery Systems (15 papers). Helen M. Burt is often cited by papers focused on Nanoparticle-Based Drug Delivery (34 papers), Cancer Treatment and Pharmacology (23 papers) and Advanced Drug Delivery Systems (15 papers). Helen M. Burt collaborates with scholars based in Canada, United States and Denmark. Helen M. Burt's co-authors include John K. Jackson, Kevin Letchford, Richard Liggins, William L. Hunter, Xichen Zhang, Katherine J. Haxton, Stephen K. Dordunoo, Mu Chiao, Martin Gleave and Jason Zastre and has published in prestigious journals such as The Journal of Immunology, Biomaterials and Advanced Drug Delivery Reviews.

In The Last Decade

Helen M. Burt

168 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes

2006 854 citations Kevin Letchford, Helen M. Burt European Journal of Pharmaceutics and Biopharmaceutics profile →

Peers

Countries citing papers authored by Helen M. Burt

Since Specialization

Citations

This map shows the geographic impact of Helen M. Burt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen M. Burt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen M. Burt more than expected).

Fields of papers citing papers by Helen M. Burt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen M. Burt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen M. Burt. The network helps show where Helen M. Burt may publish in the future.

Co-authorship network of co-authors of Helen M. Burt

This figure shows the co-authorship network connecting the top 25 collaborators of Helen M. Burt. A scholar is included among the top collaborators of Helen M. Burt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen M. Burt. Helen M. Burt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Catalyzing Clusters of Research Excellence: An Institutional Case Study. 2019 ·Kyle Demes, Gail C. Murphy, Helen M. Burt	2
2	Mixed Molecular Weight Copolymer Nanoparticles for the Treatment of Drug-Resistant Tumors: Formulation Development and Cytotoxicity 2014 ·Journal of Pharmaceutical Sciences ·(unknown), Kevin Letchford, (unknown), John K. Jackson, Helen M. Burt	6
3	Microspheres as resistive elements in a check valve for low pressure and low flow rate conditions 2012 ·Lab on a Chip ·(unknown), John K. Jackson, Helen M. Burt, Mu Chiao	14
4	In vivo Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer 2011 ·Clinical Cancer Research ·Clement Mugabe, Yoshiyuki Matsui, Alan So, Martin Gleave, Jennifer H.E. Baker, Andrew I. Minchinton, (unknown), Richard Liggins, Donald E. Brooks, Helen M. Burt	51
5	In Vitro and In Vivo Evaluation of Intravesical Docetaxel Loaded Hydrophobically Derivatized Hyperbranched Polyglycerols in an Orthotopic Model of Bladder Cancer 2011 ·Biomacromolecules ·Clement Mugabe, Yoshiyuki Matsui, Alan So, Martin Gleave, Markus Heller, Magali Zeisser Labouebe, (unknown), Irina Chafeeva, Donald E. Brooks, Helen M. Burt	27
6	Increased accumulation of paclitaxel and doxorubicin in proliferating capillary cells and prostate cancer cells following ultrasound exposure 2011 ·Ultrasonics ·John K. Jackson, Fatemeh Nazly Pirmoradi, (unknown), (unknown), Mu Chiao, Helen M. Burt	21
7	An in vitro study of plasticized poly(lactic‐co‐glycolic acid) films as possible guided tissue regeneration membranes: Material properties and drug release kinetics 2010 ·Journal of Biomedical Materials Research Part A ·Gethin Owen, John K. Jackson, Babak Chehroudi, D. M. Brunette, Helen M. Burt	36
8	PLGA and PHBV Microsphere Formulations and Solid-State Characterization: Possible Implications for Local Delivery of Fusidic Acid for the Treatment and Prevention of Orthopaedic Infections 2009 ·Pharmaceutical Research ·Chi-Ming Yang, David Plackett, David Needham, Helen M. Burt	34
9	Enhanced Gap Filling and Osteoconduction Associated with Alendronate-Calcium Phosphate-Coated Porous Tantalum 2008 ·Journal of Bone and Joint Surgery ·Donald S. Garbuz, (unknown), (unknown), Ke Duan, Bassam A. Masri, Thomas R. Oxland, Helen M. Burt, Rizhi Wang, Clivе P. Duncan	73
10	Clusterin antisense complexed with chitosan for controlled intratumoral delivery 2007 ·International Journal of Pharmaceutics ·(unknown), John K. Jackson, Martin Gleave, Helen M. Burt	15
11	Time-dependent inhibition of CYP3A4 by mibefradil in recombinant CYP3A4 and human liver microsomes and impact on in vivo predictions. 2006 ·Drug Metabolism Reviews ·Helen M. Burt, Aleksandra Galetin, (unknown)	1
12	Methoxypolyethylene Glycol-block-polycaprolactone Diblock Copolymers Reduce P-glycoprotein Efflux in the Absence of a Membrane Fluidization Effect while Stimulating P-glycoprotein ATPase Activity 2006 ·Journal of Pharmaceutical Sciences ·Jason Zastre, John K. Jackson, Wesley Wong, Helen M. Burt	35
13	Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel 2004 ·International Journal of Pharmaceutics ·John K. Jackson, (unknown), Kevin Letchford, (unknown), Lindsay Machan, Pierre Signore, William L. Hunter, Kaiyue Wang, Helen M. Burt	54
14	Synthesis and micellar characterization of short block length methoxy poly(ethylene glycol)-block-poly(caprolactone) diblock copolymers 2004 ·Colloids and Surfaces B Biointerfaces ·Kevin Letchford, Jason Zastre, Richard Liggins, Helen M. Burt	70
15	Calcium pyrophosphate dihydrate crystal associated induction of neutrophil activation and repression of TNF-α-induced apoptosis is mediated by the p38 MAP kinase 2003 ·Cellular Signalling ·Christopher Tudan, John K. Jackson, (unknown), (unknown), Steven Pelech, Helen M. Burt	11
16	Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers 2002 ·European Journal of Pharmaceutics and Biopharmaceutics ·Jason Zastre, John K. Jackson, (unknown), Richard Liggins, (unknown), Helen M. Burt	86
17	Inhibition of TNF-α-Induced Neutrophil Apoptosis by Crystals of Calcium Pyrophosphate Dihydrate Is Mediated by the Extracellular Signal-Regulated Kinase and Phosphatidylinositol 3-Kinase/Akt Pathways Up-Stream of Caspase 3 2000 ·The Journal of Immunology ·Christopher Tudan, John K. Jackson, (unknown), Steven Pelech, Helen M. Burt	28
18	Neutrophil activation by plasma opsonized polymeric microspheres: inhibitory effect of Pluronic F127 2000 ·Biomaterials ·John K. Jackson, (unknown), William L. Hunter, Helen M. Burt	47
19	Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors 2000 ·The Prostate ·Suet Yi Leung, John K. Jackson, Hideaki Miyake, Helen M. Burt, Martin Gleave	51
20	The development of a novel intraperitoneal tumor-seeding prophylactic 1997 ·The American Journal of Surgery ·(unknown), Richard Liggins, Lindsay Machan, Noelle Davis, Helen M. Burt, William L. Hunter	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact